Immunogenicity of BNT162b2 mRNA COVID-19 Vaccine in Patients with Cardiovascular Disease

Concern has been raised about the effectiveness of the coronavirus disease 2019 (COVID-19) vaccine in the population of patients with various comorbidities such as heart disease. We investigated the humoral response to the BNT162b2 mRNA COVID-19 vaccine in patients with cardiovascular disease (CVD)....

Descripción completa

Detalles Bibliográficos
Autores principales: Naruse, Hiroyuki, Ito, Hiroyasu, Izawa, Hideo, Sarai, Masayoshi, Ishii, Junnichi, Sakaguchi, Eirin, Murakami, Reiko, Ando, Tatsuya, Fujigaki, Hidetsugu, Saito, Kuniaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8658500/
https://www.ncbi.nlm.nih.gov/pubmed/34884205
http://dx.doi.org/10.3390/jcm10235498

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8658500/
https://www.ncbi.nlm.nih.gov/pubmed/34884205
http://dx.doi.org/10.3390/jcm10235498

Ejemplares similares